Skoči na glavni sadržaj

Izvorni znanstveni članak

https://doi.org/10.3325/cmj.2014.55.621

Antithrombotics in heart failure

Davor Miličić ; 1University of Zagreb Schoolof Medicine, Department forCardiovascular Diseases, UniversityHospital Center Zagreb, Zagreb,Croatia
Jure Samardžić ; 1University of Zagreb Schoolof Medicine, Department forCardiovascular Diseases, UniversityHospital Center Zagreb, Zagreb,Croatia
Mate Petričević ; Department for Cardiac Surgery, University Hospital Center Zagreb,Zagreb, Croatia


Puni tekst: engleski pdf 135 Kb

str. 621-627

preuzimanja: 449

citiraj


Sažetak

Heart failure is a common clinical condition associated with
high morbidity and mortality rate despite significant improvements
in pharmacotherapy and implementation of
medical procedures. Patients with heart failure are at an increased
risk of developing arterial and venous thrombosis,
which contribute to the high rate of adverse events and fatal
outcomes. Many heart failure patients routinely receive
antithrombotic therapy due to the presence of a specific
indication for its use, like ischemic heart disease or atrial
fibrillation. However, there is no solid evidence to support
the routine use of antithrombotic agents in all heart failure
patients. This article reviews the evidence for using antithrombotic
therapy in heart failure patients.

Ključne riječi

Hrčak ID:

139290

URI

https://hrcak.srce.hr/139290

Datum izdavanja:

15.12.2014.

Posjeta: 922 *